The Government has today (04 November) published its response to the final report of the Accelerated Access Review (AAR).
Commissioned by the government in November 2014, the AAR put forward recommendations to make it easier for NHS patients to access innovative medicines, medical technologies, diagnostics and digital products.
A key element of the Government’s response today has been the announcement of the new ‘accelerated access pathway’, which should result in products with the greatest potential to change outcomes being made available up to four years earlier
Commenting on the report, Doris-Ann Williams MBE, Chief Executive of BIVDA, said:
“Diagnosis led healthcare is the key to better outcomes but the uptake of innovative in vitro diagnostics (IVDs) within the NHS typically takes 10 years.
“BIVDA welcome’s the publication of the Government’s response to the Accelerated Access Review and through the creation of the new Accelerated Access Pathway, I hope we will see faster and wider adoption of IVDs across the NHS, for the benefit of patients, the health service and the British economy.
“We were pleased that the 2016 AAR report recommended “NICE should refocus its work to place more emphasis on medical technologies, diagnostics and precision medicine tools, and a funding requirement should apply for those products that improve efficiency”. BIVDA would welcome clarification from the Government on how they intend to support this recommendation going forwards”.